SECOND REPORTED KINDRED WITH HEREDITARY RESISTANCE TO ORAL ANTICOAGULANT DRUGS

[1] POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) : 496 - &

[2] PHYSIOLOGICAL BASIS FOR TRANSFUSION THERAPY IN HEMORRHAGIC DISORDERS - A CRITICAL REVIEW [J]. TRANSFUSION, 1961, 1 (02) : 71 - +

[3] AGGELER PM, 1969, J LAB CLIN MED, V74, P229

[4] AGGELER PM, 1966, THROMB DIATH HAEMO, P227

[5] AXELROD J, 1949, P SOC EXP BIOL MED, V70, P693, DOI 10.3181/00379727-70-17036

[6] GRAHAM JB, 1959, AM J HUM GENET, V11, P311

[7] WARFARIN METABOLISM AND VITAMIN K REQUIREMENT IN WARFARIN-RESISTANT RAT [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1969, 217 (05): : 1316 - +

[8] INCREASED PLASMA CHOLINESTERASE ACTIVITY AND SUCCINYLCHOLINE RESISTANCE - A GENETIC VARIANT [J]. JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (03) : 380 - &

[9] OREILLY RA, 1965, FED PROC, V24, P1266

[10] OREILLY RA, 1970, PHARMACOL REV, V22, P35

[1] POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) : 496 - &

[2] PHYSIOLOGICAL BASIS FOR TRANSFUSION THERAPY IN HEMORRHAGIC DISORDERS - A CRITICAL REVIEW [J]. TRANSFUSION, 1961, 1 (02) : 71 - +

[3] AGGELER PM, 1969, J LAB CLIN MED, V74, P229

[4] AGGELER PM, 1966, THROMB DIATH HAEMO, P227

[5] AXELROD J, 1949, P SOC EXP BIOL MED, V70, P693, DOI 10.3181/00379727-70-17036

[6] GRAHAM JB, 1959, AM J HUM GENET, V11, P311

[7] WARFARIN METABOLISM AND VITAMIN K REQUIREMENT IN WARFARIN-RESISTANT RAT [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1969, 217 (05): : 1316 - +

[8] INCREASED PLASMA CHOLINESTERASE ACTIVITY AND SUCCINYLCHOLINE RESISTANCE - A GENETIC VARIANT [J]. JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (03) : 380 - &

[9] OREILLY RA, 1965, FED PROC, V24, P1266

[10] OREILLY RA, 1970, PHARMACOL REV, V22, P35